Diabetes mellitus autosomal dominant type II (disorder)
|
1.000 |
CausalMutation
|
disease |
CLINVAR |
Cell biology assessment of glucokinase mutations V62M and G72R in pancreatic beta-cells: evidence for cellular instability of catalytic activity.
|
17389332 |
2007 |
Diabetes mellitus autosomal dominant type II (disorder)
|
1.000 |
GeneticVariation
|
disease |
CLINVAR |
Mutations in GCK and HNF-1alpha explain the majority of cases with clinical diagnosis of MODY in Spain.
|
17573900 |
2007 |
Diabetes mellitus autosomal dominant type II (disorder)
|
1.000 |
CausalMutation
|
disease |
CLINVAR |
Identification of novel and recurrent glucokinase mutations in Belgian and Luxembourg maturity onset diabetes of the young patients.
|
16965331 |
2006 |
Diabetes mellitus autosomal dominant type II (disorder)
|
1.000 |
GeneticVariation
|
disease |
CLINVAR |
Identification of novel and recurrent glucokinase mutations in Belgian and Luxembourg maturity onset diabetes of the young patients.
|
16965331 |
2006 |
Diabetes mellitus autosomal dominant type II (disorder)
|
1.000 |
CausalMutation
|
disease |
CLINVAR |
Glucokinase mutations in young children with hyperglycemia.
|
16444761 |
2006 |
Diabetes mellitus autosomal dominant type II (disorder)
|
1.000 |
GeneticVariation
|
disease |
UNIPROT |
Identification of novel and recurrent glucokinase mutations in Belgian and Luxembourg maturity onset diabetes of the young patients.
|
16965331 |
2006 |
Diabetes mellitus autosomal dominant type II (disorder)
|
1.000 |
CausalMutation
|
disease |
CLINVAR |
From clinicogenetic studies of maturity-onset diabetes of the young to unraveling complex mechanisms of glucokinase regulation.
|
16731834 |
2006 |
Diabetes mellitus autosomal dominant type II (disorder)
|
1.000 |
GeneticVariation
|
disease |
CLINVAR |
From clinicogenetic studies of maturity-onset diabetes of the young to unraveling complex mechanisms of glucokinase regulation.
|
16731834 |
2006 |
Diabetes mellitus autosomal dominant type II (disorder)
|
1.000 |
CausalMutation
|
disease |
CLINVAR |
Genetic and clinical characteristics of Korean maturity-onset diabetes of the young (MODY) patients.
|
16632067 |
2006 |
Diabetes mellitus autosomal dominant type II (disorder)
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Clinical characteristics of mutation carriers in a large family with glucokinase diabetes (MODY2).
|
16026363 |
2005 |
Diabetes mellitus autosomal dominant type II (disorder)
|
1.000 |
CausalMutation
|
disease |
CLINVAR |
Insights into the structure and regulation of glucokinase from a novel mutation (V62M), which causes maturity-onset diabetes of the young.
|
15677479 |
2005 |
Diabetes mellitus autosomal dominant type II (disorder)
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the glucokinase (GK) gene result in Maturity Onset Diabetes of the Young type 2 (MODY 2) and are associated with lower birthweight.
|
15918042 |
2005 |
Diabetes mellitus autosomal dominant type II (disorder)
|
1.000 |
Biomarker
|
disease |
MGD |
This collection of Gk mutants will be valuable for understanding GK gene function, for dissecting the function of the enzyme and as models of human MODY2 and PNDM.
|
15102714 |
2004 |
Diabetes mellitus autosomal dominant type II (disorder)
|
1.000 |
Biomarker
|
disease |
MGD |
A new mouse model of type 2 diabetes, produced by N-ethyl-nitrosourea mutagenesis, is the result of a missense mutation in the glucokinase gene.
|
15161764 |
2004 |
Diabetes mellitus autosomal dominant type II (disorder)
|
1.000 |
CausalMutation
|
disease |
CLINVAR |
Glucokinase (GCK) mutations in hyper- and hypoglycemia: maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemia of infancy.
|
14517946 |
2003 |
Diabetes mellitus autosomal dominant type II (disorder)
|
1.000 |
Biomarker
|
disease |
MGD |
Novel phenotypes identified by plasma biochemical screening in the mouse.
|
12420138 |
2002 |
Diabetes mellitus autosomal dominant type II (disorder)
|
1.000 |
GeneticVariation
|
disease |
CLINVAR |
GCK and HNF1A mutations in Canadian families with maturity onset diabetes of the young (MODY).
|
12442280 |
2002 |
Diabetes mellitus autosomal dominant type II (disorder)
|
1.000 |
GeneticVariation
|
disease |
CLINVAR |
High prevalence of glucokinase mutations in Italian children with MODY. Influence on glucose tolerance, first-phase insulin response, insulin sensitivity and BMI.
|
11508276 |
2001 |
Diabetes mellitus autosomal dominant type II (disorder)
|
1.000 |
CausalMutation
|
disease |
CLINVAR |
High prevalence of glucokinase mutations in Italian children with MODY. Influence on glucose tolerance, first-phase insulin response, insulin sensitivity and BMI.
|
11508276 |
2001 |
Diabetes mellitus autosomal dominant type II (disorder)
|
1.000 |
GeneticVariation
|
disease |
UNIPROT |
Neonatal diabetes mellitus due to complete glucokinase deficiency.
|
11372010 |
2001 |
Diabetes mellitus autosomal dominant type II (disorder)
|
1.000 |
GeneticVariation
|
disease |
CLINVAR |
"MODY 2 presenting as neonatal hyperglycaemia: a need to reshape the definition of ""neonatal diabetes""?"
|
11079754 |
2000 |
Diabetes mellitus autosomal dominant type II (disorder)
|
1.000 |
GeneticVariation
|
disease |
UNIPROT |
Identification of glucokinase mutation in subjects with post-renal transplantation diabetes mellitus.
|
11106831 |
2000 |
Diabetes mellitus autosomal dominant type II (disorder)
|
1.000 |
CausalMutation
|
disease |
CLINVAR |
A high prevalence of glucokinase mutations in gestational diabetic subjects selected by clinical criteria.
|
10753050 |
2000 |
Diabetes mellitus autosomal dominant type II (disorder)
|
1.000 |
Biomarker
|
disease |
MGD |
Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knock-outs using Cre recombinase.
|
9867845 |
1999 |
Diabetes mellitus autosomal dominant type II (disorder)
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
The enzymatic activity and thermal stability of wild-type (WT) GK and several mutant forms associated with maturity-onset diabetes of the young type 2 (MODY-2) were determined by a steady-state kinetic analysis of the purified expressed proteins.
|
10426385 |
1999 |